Skip to main content
CLDX logo

CLDX · Celldex Therapeutics, Inc. · Executive Compensation

Track CLDX — free
$31.65 -0.53 (-1.65%) At close · Oct 2
Market Cap
$2.50B
Shares
78.53M
Volume · Oct 2 2.41M Avg daily vol (3M) 1.26M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Denice Torres Appointed 2026-06-26
Rita I. Jain, M.D. Appointed 2026-06-26
Garry A. Neil, M.D. Appointed 2026-06-26
James J. Marino Appointed 2026-06-26
Cheryl L. Cohen Appointed 2026-06-26
Herbert J. Conrad Appointed 2026-06-26
Keith L. Brownlie Appointed 2026-06-26
Denice Torres Appointed 2025-06-06
Harry H. Penner, Jr. Appointed 2025-06-06
Harry H. Penner, Jr. Appointed 2025-06-06
James J. Marino Appointed 2025-06-06
Garry A. Neil, M.D. Appointed 2025-06-06
Herbert J. Conrad Appointed 2025-06-06
Rita I. Jain, M.D. Appointed 2025-06-06
Cheryl L. Cohen Appointed 2025-06-06
Keith L. Brownlie Appointed 2025-06-06
Anthony S. Marucci Appointed 2025-06-06
Harry H. Penner, Jr. Appointed 2024-06-14
Garry A. Neil, M.D. Appointed 2024-06-14
James J. Marino Appointed 2024-06-14
Rita I. Jain, M.D. Appointed 2024-06-14
Herbert J. Conrad Appointed 2024-06-14
Cheryl L. Cohen Appointed 2024-06-14
Keith L. Brownlie Appointed 2024-06-14
Anthony S. Marucci Appointed 2024-06-14
Key facts CIK 744218 CUSIP 15117B202 13F (30d) 5 filings 5 filers Visit website Investor relations